Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Ibuprofen
Pedea
Routinely available
SMC (233/06)
01/09/2006
Indication
Haemodynamically significant patent ductus arteriosus in pre-term newborn infants of less than 34 weeks gestational age
Therapeutic Area
Cardiovascular system
Status Description
Routinely available in line with national guidance
Formulation
5mg/ml intravenous injection
Comments
September 2006 - Added to the LJF for Children as second choice for the treatment of closure of the ductus arteriosus. June 2019 (as per LJF) - Routinely available in line with national guidance. Included in the LJF.
Link to Advice
Advice Published
13/02/2006
SMC Submission Type
Abbreviated
SMC Status
Accepted